Recombinant human endostatin enhances the radioresponse in esophageal squamous cell carcinoma by normalizing tumor vasculature and reducing hypoxia [PDF]
, 2015 Hongcheng Zhu +15 more
openalex +1 more source
A single-center, retrospective study-spring-evaluating the efficacy and safety of recombinant human vascular endothelial inhibitor combined with anti-PD-1 in elderly patients aged 80 and above with NSCLC. [PDF]
Front ImmunolXing T, Gao Q, Zhu H, Gao J, Yan G.
europepmc +1 more source
Recent Trends in Medical Management of Endometriosis. [PDF]
J Obstet Gynaecol IndiaPatel M.
europepmc +1 more source
Serum Endostatin Levels in Oral Squamous Cell Carcinoma.
, 2018 Maryam Mardani +5 more
openalex +1 more source
Interaction of endostatin with integrins implicated in angiogenesis
, 2001 Marko Rehn +8 more
openalex +1 more source
Endostatin as a biomarker of systemic sclerosis: insights from a systematic review and meta-analysis. [PDF]
Front ImmunolMangoni AA, Zinellu A.
europepmc +1 more source
Real-world effectiveness and safety of recombinant human endostatin plus PD-1 inhibitors and chemotherapy as first-line treatment for EGFR/ALK-negative, advanced or metastatic non-small cell lung cancer. [PDF]
BMC CancerZhang J +7 more
europepmc +1 more source
Immunotherapy combined with antiangiogenic therapy as third- or further-line therapy for stage IV non-small cell lung cancer patients with ECOG performance status 2: A retrospective study. [PDF]
Cancer MedLi S +6 more
europepmc +1 more source